Literature DB >> 28339772

Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.

Qian Shi1, Minghui Li1,2, Delphine Mika3, Qin Fu4, Sungjin Kim1, Jason Phan1, Ao Shen1, Gregoire Vandecasteele3, Yang K Xiang1,5.   

Abstract

AIMS: Cardiac β-adrenergic receptor (βAR) signalling is susceptible to heterologous desensitization by different neurohormonal stimuli in clinical conditions associated with heart failure. We aim to examine the underlying mechanism of cross talk between βARs and a set of G-protein coupled receptors (GPCRs) activated by hormones/agonists. METHODS AND
RESULTS: Rat ventricular cardiomyocytes were used to determine heterologous phosphorylation of βARs under a series of GPCR agonists. Activation of Gs-coupled dopamine receptor, adenosine receptor, relaxin receptor and prostaglandin E2 receptor, and Gq-coupled α1 adrenergic receptor and angiotensin II type 1 receptor promotes phosphorylation of β1AR and β2AR at putative protein kinase A (PKA) phosphorylation sites; but activation of Gi-coupled α2 adrenergic receptor and activation of protease-activated receptor does not. The GPCR agonists that promote β2AR phosphorylation effectively inhibit βAR agonist isoproterenol-induced PKA phosphorylation of phospholamban and contractile function in ventricular cardiomyocytes. Heterologous GPCR stimuli have minimal to small effect on isoproterenol-induced β2AR activation and G-protein coupling for cyclic adenosine monophosphate (cAMP) production. However, these GPCR stimuli significantly promote phosphorylation of phosphodiesterase 4D (PDE4D), and recruit PDE4D to the phosphorylated β2AR in a β-arrestin 2 dependent manner without promoting β2AR endocytosis. The increased binding between β2AR and PDE4D effectively hydrolyzes cAMP signal generated by subsequent stimulation with isoproterenol. Mutation of PKA phosphorylation sites in β2AR, inhibition of PDE4, or genetic ablation of PDE4D or β-arrestin 2 abolishes this heterologous inhibitory effect. Ablation of β-arrestin 2 or PDE4D gene also rescues β-adrenergic stimuli-induced myocyte contractile function.
CONCLUSIONS: These data reveal essential roles of β-arrestin 2 and PDE4D in a common mechanism for heterologous desensitization of cardiac βARs under hormonal stimulation, which is associated with impaired cardiac function during the development of pathophysiological conditions. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Heterologous desensitization; PKA; PKC; Phosphodiesterase 4; β-Arrestin 2

Mesh:

Substances:

Year:  2017        PMID: 28339772      PMCID: PMC5852637          DOI: 10.1093/cvr/cvx036

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  73 in total

Review 1.  Seven-transmembrane-spanning receptors and heart function.

Authors:  Howard A Rockman; Walter J Koch; Robert J Lefkowitz
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Arresting developments in heptahelical receptor signaling and regulation.

Authors:  Stephen J Perry; Robert J Lefkowitz
Journal:  Trends Cell Biol       Date:  2002-03       Impact factor: 20.808

3.  GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Authors:  Lionel Moulédous; Carine Froment; Stéphanie Dauvillier; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 4.  Nanobody stabilization of G protein-coupled receptor conformational states.

Authors:  Jan Steyaert; Brian K Kobilka
Journal:  Curr Opin Struct Biol       Date:  2011-07-21       Impact factor: 6.809

5.  Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.

Authors:  Karnam S Murthy; Wimolpak Sriwai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-15       Impact factor: 4.052

6.  Cardiac effects of relaxin in rats.

Authors:  H Kakouris; L W Eddie; R J Summers
Journal:  Lancet       Date:  1992-05-02       Impact factor: 79.321

7.  Cytokine-induced iNOS and ERK1/2 inhibit adenylyl cyclase type 5/6 activity and stimulate phosphodiesterase 4D5 activity in intestinal longitudinal smooth muscle.

Authors:  Sunila Mahavadi; Ancy D Nalli; Divya P Kumar; Wenhui Hu; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

8.  Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.

Authors:  Vania De Arcangelis; Ruijie Liu; Dagoberto Soto; Yang Xiang
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

9.  Conformational biosensors reveal GPCR signalling from endosomes.

Authors:  Roshanak Irannejad; Jin C Tomshine; Jon R Tomshine; Michael Chevalier; Jacob P Mahoney; Jan Steyaert; Søren G F Rasmussen; Roger K Sunahara; Hana El-Samad; Bo Huang; Mark von Zastrow
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

10.  Visualization of arrestin recruitment by a G-protein-coupled receptor.

Authors:  Arun K Shukla; Gerwin H Westfield; Kunhong Xiao; Rosana I Reis; Li-Yin Huang; Prachi Tripathi-Shukla; Jiang Qian; Sheng Li; Adi Blanc; Austin N Oleskie; Anne M Dosey; Min Su; Cui-Rong Liang; Ling-Ling Gu; Jin-Ming Shan; Xin Chen; Rachel Hanna; Minjung Choi; Xiao Jie Yao; Bjoern U Klink; Alem W Kahsai; Sachdev S Sidhu; Shohei Koide; Pawel A Penczek; Anthony A Kossiakoff; Virgil L Woods; Brian K Kobilka; Georgios Skiniotis; Robert J Lefkowitz
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

View more
  12 in total

Review 1.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

2.  Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β2 -adrenergic receptor.

Authors:  Thomas C Rich; Silas J Leavesley; Angela P Brandon; Cilina A Evans; S Vamsee Raju; Brant M Wagener
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

Review 3.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

Review 4.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 5.  Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress.

Authors:  Gabriel Komla Adzika; Jeremiah Ong'achwa Machuki; Wenkang Shang; Hongjian Hou; Tongtong Ma; Lijuan Wu; Juan Geng; Xide Hu; Xianluo Ma; Hong Sun
Journal:  J Mol Med (Berl)       Date:  2019-05-06       Impact factor: 4.599

6.  Intracellular β1-Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility.

Authors:  Ying Wang; Qian Shi; Minghui Li; Meimi Zhao; Raghavender Reddy Gopireddy; Jian-Peng Teoh; Bing Xu; Chaoqun Zhu; Kyle E Ireton; Sanghavi Srinivasan; Shaoliang Chen; Paul J Gasser; Julie Bossuyt; Johannes W Hell; Donald M Bers; Yang K Xiang
Journal:  Circ Res       Date:  2020-11-13       Impact factor: 17.367

Review 7.  Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease.

Authors:  Laurel A Grisanti; Sarah M Schumacher; Douglas G Tilley; Walter J Koch
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

8.  Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β1-Adrenergic Receptors.

Authors:  Misun Park; Susan F Steinberg
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

9.  Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.

Authors:  Qingtong Wang; Ying Wang; Toni M West; Yongming Liu; Gopireddy R Reddy; Federica Barbagallo; Bing Xu; Qian Shi; Bingqing Deng; Wei Wei; Yang K Xiang
Journal:  Cardiovasc Res       Date:  2021-08-29       Impact factor: 10.787

10.  Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3.

Authors:  Yinquan Fang; Qingling Jiang; Shanshan Li; Hong Zhu; Rong Xu; Nanshan Song; Xiao Ding; Jiaqi Liu; Miaomiao Chen; Mengmeng Song; Jianhua Ding; Ming Lu; Guangyu Wu; Gang Hu
Journal:  Cell Death Differ       Date:  2021-03-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.